Pennant Group, Inc. (PNTG) Stock Analysis and Metrics

Pennant

NASDAQ: PNTG

$41.95 ▲ +0.24 (+0.58%)

At close: Jul 17, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap1.30 Bn

P/E36.51

P/S1.27

Div. Yield0.00

ROIC (Qtr)0.00

Total Debt (Qtr)5.00 Mn

Revenue Growth (1y) (Qtr)35.99

Add ratio to table…

About

Pennant Group, Inc. is a leading provider of high-quality healthcare services to patients, residents, and clients of all ages, including the growing senior population, in the United States. The company operates home health, hospice, and senior living services across multiple states. It delivers care through a decentralized model that empowers local leaders to make decisions based on community needs.

Pennant Group, Inc. generates revenue from a diversified blend of payors including Medicare and Medicaid programs, private pay patients and residents, and managed care payors. The company provides services through 172 home health and hospice agencies and 63 senior living communities with 4,428 total units. Revenue is derived from clinical services such as nursing, therapy, medical social work, and residential care offerings tailored to resident needs.

Pennant Group, Inc. operates through the following segments:

• Home health and hospice services: This segment includes home health, hospice, home care, and geriatric primary and palliative care businesses. It provides clinical services such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services within a patient's home. The segment also offers case management, personal care, and assistance with activities of daily living through home care services.

• Senior living services: This segment includes assisted living, independent living, and memory care services. It provides residential accommodations, activities, meals, housekeeping, and assistance with activities of daily living for seniors who are independent or require some support but not at the level of clinical care in a skilled nursing facility. Revenue in this segment is primarily generated from private pay sources, with supplementation from Medicaid or other state-specific programs in certain states.

Pennant Group, Inc. holds a competitive position in the fragmented home health, hospice, and senior living industries through its innovative operating model that emphasizes local decision-making and peer accountability. The company differentiates itself by recruiting and developing talented local leaders, achieving quality care outcomes in cost-effective settings, and maintaining a disciplined growth strategy. Its ability to build strong community relationships and deliver tailored services supports its reputation as a preferred provider in local markets.

Pennant Group, Inc. serves patients, residents, and clients across the United States, including the growing senior population. The company’s customer base includes individuals receiving home health and hospice care, seniors in assisted living, independent living, and memory care communities, and referral sources such as hospitals and post-acute providers. It also works with payors including Medicare, Medicaid, managed care organizations, and private pay individuals and families.

Investment Thesis

▲ Bull case

The company has built a deep leadership pipeline with over 150 C level leaders added in the past two years which creates a sustainable foundation for future growth and operational consistency. This investment in talent has already translated into improved same store margins as seen by the 110 basis point rise in home health and hospice adjusted EBITDA prior to NCI and the 190 basis point increase in senior living segment margins. The ability to attract and develop leaders allows the firm to replicate its operating model across new markets and to integrate acquisitions without eroding profitability. As the pipeline continues to strengthen the company is positioned to deliver margin expansion that the market has not yet fully priced into the stock.
The ongoing integration of the Southeast operations is progressing on schedule with two of five transition waves completed and the remaining waves expected to be finished by the end of the third quarter. While transition services agreement costs are currently pressuring margins the company anticipates a significant roll off of these expenses once the integration is complete which should unlock hidden earnings power. Management noted that same store performance remained strong despite the integration headwinds indicating that the core business is healthy and ready to benefit from lower costs. When the transition costs disappear the adjusted EBITDA margin could move toward the stated 18% target providing a clear catalyst for earnings growth.
The firm is actively pursuing joint ventures with integrated health care systems a channel that has historically delivered accretive returns and expands the addressable market for home health and hospice services. These partnerships allow Pennant to tap into referral networks that favor high quality low cost providers and to share the financial risk of new market entry. The company’s track record of reducing hospital readmissions and mortality rates makes it an attractive partner for health systems seeking to improve their care continuum. As more joint venture opportunities arise the revenue base could grow faster than organic same store trends alone suggesting upside that is not reflected in current guidance.

The company has built a deep leadership pipeline with over 150 C level leaders added in the past two years which creates a sustainable foundation for future growth and operational consistency. This investment in talent has already translated into improved same store margins as seen by the 110 basis point rise in home health and hospice adjusted EBITDA prior to NCI and the 190 basis point increase in senior living segment margins. The ability to attract and develop leaders allows the firm to replicate its operating model across new markets and to integrate acquisitions without eroding profitability. As the pipeline continues to strengthen the company is positioned to deliver margin expansion that the market has not yet fully priced into the stock.
The ongoing integration of the Southeast operations is progressing on schedule with two of five transition waves completed and the remaining waves expected to be finished by the end of the third quarter. While transition services agreement costs are currently pressuring margins the company anticipates a significant roll off of these expenses once the integration is complete which should unlock hidden earnings power. Management noted that same store performance remained strong despite the integration headwinds indicating that the core business is healthy and ready to benefit from lower costs. When the transition costs disappear the adjusted EBITDA margin could move toward the stated 18% target providing a clear catalyst for earnings growth.
The firm is actively pursuing joint ventures with integrated health care systems a channel that has historically delivered accretive returns and expands the addressable market for home health and hospice services. These partnerships allow Pennant to tap into referral networks that favor high quality low cost providers and to share the financial risk of new market entry. The company’s track record of reducing hospital readmissions and mortality rates makes it an attractive partner for health systems seeking to improve their care continuum. As more joint venture opportunities arise the revenue base could grow faster than organic same store trends alone suggesting upside that is not reflected in current guidance.

▼ Bear case

Labor cost pressures remain a persistent headwind with wage inflation continuing to elevate expenses across the home health hospice and senior living segments. The company acknowledged ongoing wage pressure in the call and noted that it is mitigating the impact through productivity initiatives but there is no guarantee that efficiency gains will fully offset rising labor rates. If wage growth outpaces productivity improvements the adjusted EBITDA margin could stagnate or decline despite revenue growth. This risk is especially relevant given the competitive nature of the healthcare labor market and the potential for further regulatory changes affecting overtime or staffing ratios.
Medicare reimbursement rates are facing downward pressure as evidenced by the one point three% reduction in the home health base rate and the continued scrutiny of hospice caps which limit reimbursement for longer stays. The company relies on value based purchasing and clinical efficiencies to offset these cuts but the sustainability of those offsets is uncertain especially if regulatory adjustments become more frequent or severe. A prolonged period of base rate erosion would compress margins and force the firm to rely increasingly on acquisition growth to maintain earnings momentum. The market may be underestimating the magnitude of this reimbursement headwind.
The company’s growth strategy remains heavily dependent on acquisitions which introduces integration risk and potential for goodwill impairment if acquired assets underperform. While recent acquisitions have been integrated successfully the pace of deals could slow if suitable targets become scarce or if financing costs rise. The net debt to adjusted EBITDA ratio of one point nine three times indicates a modest leverage position but any increase in debt to fund further acquisitions could raise financial risk and limit flexibility. Investors concerned about execution risk may view the reliance on mergers and acquisitions as a vulnerability that could hinder long term value creation.

Labor cost pressures remain a persistent headwind with wage inflation continuing to elevate expenses across the home health hospice and senior living segments. The company acknowledged ongoing wage pressure in the call and noted that it is mitigating the impact through productivity initiatives but there is no guarantee that efficiency gains will fully offset rising labor rates. If wage growth outpaces productivity improvements the adjusted EBITDA margin could stagnate or decline despite revenue growth. This risk is especially relevant given the competitive nature of the healthcare labor market and the potential for further regulatory changes affecting overtime or staffing ratios.
Medicare reimbursement rates are facing downward pressure as evidenced by the one point three% reduction in the home health base rate and the continued scrutiny of hospice caps which limit reimbursement for longer stays. The company relies on value based purchasing and clinical efficiencies to offset these cuts but the sustainability of those offsets is uncertain especially if regulatory adjustments become more frequent or severe. A prolonged period of base rate erosion would compress margins and force the firm to rely increasingly on acquisition growth to maintain earnings momentum. The market may be underestimating the magnitude of this reimbursement headwind.
The company’s growth strategy remains heavily dependent on acquisitions which introduces integration risk and potential for goodwill impairment if acquired assets underperform. While recent acquisitions have been integrated successfully the pace of deals could slow if suitable targets become scarce or if financing costs rise. The net debt to adjusted EBITDA ratio of one point nine three times indicates a modest leverage position but any increase in debt to fund further acquisitions could raise financial risk and limit flexibility. Investors concerned about execution risk may view the reliance on mergers and acquisitions as a vulnerability that could hinder long term value creation.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Medical Care Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	HCA	HCA Healthcare, Inc.	87.94 Bn	11.25	1.15	48.02 Bn
2	CHE	Chemed Corp	18.08 Bn	51.68	7.12	0.09 Bn
3	THC	Tenet Healthcare Corp	16.59 Bn	9.74	0.77	13.21 Bn
4	DVA	Davita Inc.	15.37 Bn	14.02	1.10	10.63 Bn
5	EHC	Encompass Health Corp	10.07 Bn	654.20	1.66	2.57 Bn
6	ENSG	Ensign Group, Inc	9.52 Bn	27.18	1.81	0.14 Bn
7	UHS	Universal Health Services Inc	9.19 Bn	6.05	0.52	4.71 Bn
8	PACS	PACS Group, Inc.	6.96 Bn	28.55	1.28	0.05 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password